Guidance Documents Library

Title Areasort descending
Communicable Diseases Funding DPH
Board for Evaluation of Interpreters (BEI): Test of English Proficiency (TEP) DPH
Wisconsin Well Woman Program Breast and Cervical Cancer Screening Activity Report (ARF) DPH
Guidance Related to Viral Whole Genome Sequencing of SARS-CoV-2 for the Public Health Response DPH
Adults at Risk/Elder Abuse/Protective Services Guide for IRIS Consultants DPH
Aminomethylphosphonic Acid (AMPA) - 2019 Cycle 10 DPH
How to Give Naloxone DPH
Communicable Disease Case Reporting and Investigation Protocol: Pertussis DPH
WIC Shopping Guide DPH
Important Information for Recipients of Personal Protective Equipment (PPE) from the Strategic National Stockpile (SNS) DPH
1,2,3-Trichloropropane - 2019 Cycle 10 DPH
Wisconsin Well Woman Program Breast Cancer Diagnostic and Follow-up Report (DRF) DPH
First Responders as Members of a Legal Crew DPH
Imidacloprid - 2019 Cycle 10 DPH
Statewide Naloxone Standing Order for Pharmacist DPH
Coronavirus Disease 2019 (COVID-19) Update: Recommendations on Domestic and International Travel DPH
Communicable Disease Case Reporting and Investigation Protocol: Rubella and Congenital Rubella Syndrome (CRS) DPH
Notice to Employees - Radiation Protection DPH
Important Guidance for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) (REVISED) in Long-Term Care Facilities and Assisted Living Facilities DPH
Reporting Instructions for Ductograms, Galactograms, and MRIs DPH
Arbovirus Management Protocol DPH
Wisconsin Well Woman Program Cervical Cancer Diagnostic and Follow-up Report (DRF) DPH
Latent Tuberculosis Infection (LTBI) as a Reportable Condition in Wisconsin DPH
Information for Local Boards of Health DPH
Using Text Messaging for Communicable Disease Follow-up at Local Health Departments DPH
Naloxone Administration in Outpatient Mental Health and Substance Use Disorder Clinics DQA
Fire Watch, Fire Plan, and Fire Reporting Update DQA
Construction Requirement for New 'Class C' Structures DQA
DQA - Provider Relationships During the Nursing Home Survey Process Shared Expectations DQA
Emergency Preparedness Regulations: Long-Term Care DQA
Regulatory Requirements Related to Misappropriation of Medications in Assisted Living DQA
Guidelines for Victim Advocate Accompaniment During Hospital Exams and Consultations DQA
2019 and 2020 Consumer Information Reports for Nursing Homes and Facilities for People with Developmental Disabilities DQA
Hospice and Community-Based Residential Facility Review Submittal Change DQA
Centralization of Assisted Living Licensing/Certification/Registration Process DQA
Regulatory Oversight of Community-Based Residential Facilities DQA
Defining "Skilled Care" for Wisconsin Home Health Agency (HHA) Licensure DQA
Independent Informal Dispute Resolution for Federally-Certified Nursing Homes DQA
Informal Dispute Resolution for Nursing Homes and Facilities Serving People with Developmental Disabilities DQA
Psychotropic Medications - Assisted Living DQA
DQA Provider Training DQA
Guidance Reminder Regarding Handheld Devices and the Potential Misuse of Such Devices DQA
Informal Dispute Resolution for Medicare-Certified Home Health Agencies DQA
Controlled Substances – Quick Reference for Schedule DQA
Regulatory Authority for Health Care Construction Plan Review DQA
Medication Pass: Dietary Supplements, Natural Products, Vitamins, Herbals DQA
Laboratory Certification Requirements for Certified Mental Health and Substance Abuse Programs DQA
Your Right to Direct Your Future Health Care Needs DQA
Section DHS 132.84 (2) (e) Sharing of toilet facilities between sexes DQA
Wisconsin Caregiver Program: Rehabilitation Review Process DQA

Pages

Last Revised: November 23, 2020